SCHEMBL9106658

SCHEMBL9106658

O=C1C(=O)N(C(CC2CCCC2)C(=O)Nc2ccccn2)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 10/20 0.57
CDK1 P06493 2/20 0.46
GSK3A P49840 1/20 0.46
GSK3B P49841 1/20 0.46
CDK5 Q00535 1/20 0.46
CDK5R1 Q15078 1/20 0.46
CCNB2 O95067 1/20 0.45
LCK P06239 1/20 0.45
PDGFRB P09619 1/20 0.45
FGFR1 P11362 1/20 0.45
CDK4 P11802 1/20 0.45
CCNB1 P14635 1/20 0.45
FLT1 P17948 1/20 0.45
CCNA2 P20248 1/20 0.45
CCND1 P24385 1/20 0.45
CDK2 P24941 1/20 0.45
CCNA1 P78396 1/20 0.45
CDK6 Q00534 1/20 0.45
CCNB3 Q8WWL7 1/20 0.45
ALDH1A1 P00352 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9908076 0.90 GCK (0.58) GCKCDK5CDK5R1GAA
SCHEMBL9108714 0.90 GCK (0.58) GCKCDK5CDK5R1GAA
SCHEMBL9106408 0.89 GCK (0.57) GCKKDM4E
SCHEMBL9105268 0.89 GCK (0.55) GCKCDK1GSK3AGSK3BCDK5
SCHEMBL9107581 0.89 GCK (0.55) GCKCDK1GSK3AGSK3BCDK5
SCHEMBL9104481 0.89 GCK (0.55) GCKCDK1GSK3AGSK3BCDK5
SCHEMBL9908106 0.89 GCK (0.55) GCKCDK1GSK3AGSK3BCDK5
SCHEMBL9108287 0.86 GCK (0.55) GCKALDH1A1MEN1KMT2ANPSR1
SCHEMBL9106999 0.86 GCK (0.56) GCKCDK1GSK3AGSK3BCDK5
SCHEMBL9106819 0.84 GCK (0.51) GCKKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US claimed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT GCK 488/4885CDK1 1198/4885GSK3A 2763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.